08/14/2025 6:53 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/22/2025 6:36 AM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2025 9:38 AM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/09/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2025 11:01 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2025 5:25 PM | CZIRR JAMES C (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2025 4:18 PM | CZIRR JAMES C (Reporting) Galectin Therapeutics (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
05/15/2025 6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/12/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for GALT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/31/2025 6:50 AM | Galectin Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/31/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2025 3:00 PM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2025 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/30/2025 11:40 AM | Galectin Therapeutics (Issuer) Shlevin Harold H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2025 3:03 PM | CARSON BENJAMIN SR (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:03 PM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:04 PM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:05 PM | Galectin Therapeutics (Issuer) Jamil Khurram (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:06 PM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:06 PM | Galectin Therapeutics (Issuer) OMENN GILBERT S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:07 PM | Galectin Therapeutics (Issuer) Rubin Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:01 PM | Galectin Therapeutics (Issuer) OMENN GILBERT S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:02 PM | CALLICUTT JACK W (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/23/2025 10:15 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/13/2025 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/31/2024 6:45 AM | Galectin Therapeutics (Issuer) Shlevin Harold H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:20 AM | Galectin Therapeutics (Issuer) Jamil Khurram (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:16 AM | Galectin Therapeutics (Issuer) Zordani Richard A. Jr. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:18 AM | CALLICUTT JACK W (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:18 AM | Galectin Therapeutics (Issuer) LEWIS JOEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:02 AM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2024 7:07 AM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 3:17 PM | CALLICUTT JACK W (Reporting) Galectin Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024 3:18 PM | Galectin Therapeutics (Subject) LEWIS JOEL (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024 3:19 PM | Galectin Therapeutics (Subject) Jamil Khurram (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024 6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/03/2024 7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
Overnight moves = possibly bigger returns (Ad) Here’s a chart everyone should see that dates back to 1993…
As you can see, the top line shows the much bigger average market return from trading overnight…
Versus the bottom line, which shows the more modest average return from trading during the day.
Look at that gigantic difference!
So if you prefer nice big overnight returns instead, I agree with you.
That’s why I’ve designed a breakthrough trade to tap into that overnight trading frenzy.
You can check that out right here.
Obviously, I won’t make any reckless guarantees in the stock market, but…
That eye-opening chart above is just the beginning of the benefits you’ll see to trading overnight.
PLUS, you’ll also see what my #1 ranked asset is in the entire market…
And what my “hands-off” stocks are that I wouldn’t touch with a 100-foot pole. Check out the breakthrough overnight trade before I take the video down. |
12/03/2024 7:04 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
12/03/2024 7:05 AM | Galectin Therapeutics (Filer)
| Form ARS | |
11/14/2024 6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024 12:39 PM | ELDRED KARY (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 3:12 PM | FREEMAN KEVIN D (Reporting) Galectin Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 3:10 PM | Boudes Pol F (Reporting) Galectin Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024 7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |